Meridian is conducting a clinical trial for an investigational migraine medication. Migraines are usually accompanied by moderate to severe headaches, nausea, and hypersensitivity to light and sound. Attacks generally last between 4 and 72 hours, and can place a significant burden on work, family, and quality of life.
If you frequently experience migraines, you may be eligible to join this clinical trial.
Eligible participants…
- Must be age 18 to 75
- Must experience 4 to 15 migraines per month
- Must have experienced migraines for at least a year before joining the study
- May qualify for compensation. Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Study Location(s)
Meridian Clinical Research
6602 Waters Avenue, Building C
Savannah, GA 31406
Submit Your Information
© 2018 MERIDIAN CLINICAL RESEARCH | Privacy Policy